Home > Insider Trading > Filing (0000899243-21-026766)

Filing Details

Accession Number:: 0000899243-21-026766
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-06-30 17:00:29
Reporting Period:: 2021-06-28

Accepted Time:: 2021-06-30 17:00:29
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1826457	Monte Rosa Therapeutics Inc.	GLUE	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1687880	Versant Venture Capital Vi, L.p.	One Sansome Street, Suite 3630 San Francisco CA 94104	No	No	Yes	No
1765253	Versant Vantage I, L.p.	One Sansome Street, Suite 3630 San Francisco CA 94104	No	No	Yes	No
1777651	Versant Vantage I Gp, L.p.	One Sansome Street, Suite 3630 San Francisco CA 94104	No	No	Yes	No
1777652	Versant Ventures Vi Gp-Gp, Llc	One Sansome Street, Suite 3630 San Francisco CA 94104	No	No	Yes	No
1777653	Versant Vantage I Gp-Gp, Llc	One Sansome Street, Suite 3630 San Francisco CA 94104	No	No	Yes	No
1777654	Versant Ventures Vi Gp, L.p.	One Sansome Street, Suite 3630 San Francisco CA 94104	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-06-28	6,515,869	$0.00	6,799,115	No	4	C	Direct
Common Stock	Acquisiton	2021-06-28	1,940,043	$0.00	1,940,043	No	4	C	Indirect	By Versant Vantage I, L.P.
Common Stock	Acquisiton	2021-06-28	157,895	$19.00	2,097,938	No	4	P	Indirect	By Versant Vantage I, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	C	Indirect	By Versant Vantage I, L.P.
No	4	P	Indirect	By Versant Vantage I, L.P.

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A convertible preferred stock	Disposition	2021-06-28	20,004,280	$0.00	5,666,131	$0.00
Common Stock	Series B convertible preferred stock	Disposition	2021-06-28	3,000,000	$0.00	849,738	$0.00
Common Stock	Series B convertible preferred stock	Disposition	2021-06-28	4,150,000	$0.00	1,175,470	$0.00
Common Stock	Series C convertible preferred stock	Disposition	2021-06-28	2,699,328	$0.00	764,573	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Each share of Series A convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the "Preferred Stock") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a 3.5305-for-one basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date.
Shares held by Versant Venture Capital VI, L.P. ("Versant VI"). Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP GP") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon, a member of the Issuer's board of directors, is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI. Each of Versant Ventures VI GP, Versant Ventures VI GP-GP and Bradley J. Bolzon disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports
Shares held by Versant Vantage I, L.P. ("Versant Vantage I"). Versant Vantage I GP, L.P. ("Versant Vantage I GP") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC ("Versant Vantage I GP-GP") is the general partner of Versant Vantage I GP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I. Each of Versant Vantage I GP, Versant Vantage I GP-GP and Bradley J. Bolzon disclaim beneficial ownership of such securities, except to the extent of their respective pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports.